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A B S T R A C T
Background: Overnight international travels made by Finns more than doubled during 1995–2015. To estimate
risks and observe trends of travel-related notiﬁable sexually transmitted and food- and water-borne infections
(STIs and FWIs) among travellers, we analysed national reports of gonorrhoea, syphilis, hepatitis A, shigellosis,
campylobacteriosis and salmonellosis cases and related them to travel statistics.
Method: Cases notiﬁed as travel-related to the Finnish infectious diseases register were used as numerators and
overnight stays of Statistics Finland surveys as denominator. We calculated overall risks (per 100,000 travellers)
and assessed trends (using regression model) in various geographic regions.
Results: Of all travel-related cases during 1995–2015, 2304 were STIs and 70,929 FWIs. During 2012–2015,
Asia-Oceania showed highest risk estimates for gonorrhoea (11.0; 95%CI, 9.5–13), syphilis (1.4; 0.93–2.1),
salmonellosis (157; 151–164), and campylobacteriosis (135; 129–141), and Africa for hepatitis A (4.5; 2.5–7.9),
and shigellosis (35; 28–43). When evaluating at country level, the highest risks of infections was found in
Thailand, except for hepatitis A ranking Hungary the ﬁrst. During 2000–2011, signiﬁcantly decreasing trends
occurred for most FWIs particularly in the European regions and for STIs in Russia-Baltics.
Conclusions: Our ﬁndings can be used in targeting pre-travel advice, which should also cover those visiting
Thailand or European hepatitis A risk areas.
1. Introduction
International travel has constantly increased during the last six
decades. Arrivals doubled globally during 1995–2014 from 500 million
to 1.1 billion, and the trend is set to continue [1]. Recent studies of
Finnish travellers abroad have shown that infections outnumber all
other health problems [2,3]. Two types of infections are frequent
hallmarks of foreign travel: gastro-intestinal infections (traveller's
diarrhoea), which represent the most common health problems tra-
vellers encounter [3] and sexually-transmitted infections as they easily
spread further and may have severe consequences [4,5].
Few studies have described travel-associated faecal-orally trans-
mitted infections in the North-Western European region [6–10]. In
Finland, prospective studies with volunteers have focused on travellers'
diarrhoea [11], or health problems in general [3], while nation-wide
studies have been based on data from an assistance organization, which
has been combined with travel statistics [2,12]. Investigations using
retrospective study design or conducted on those seeking post-travel
medical care are scarce.
To the best of our knowledge, the National Infectious Diseases
Register (NIDR) data have only twice been combined with nation-wide
travel statistics in scientiﬁc publications [13,14], however, Finland
represents one of the few countries collecting and publishing their data
on annual number of travellers to various destinations [2]. Such an
approach allows us to estimate risks of acquiring travel-related infec-
tions.
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We performed a retrospective record-based review and analysis of
travel-acquired notiﬁable infections among Finnish travellers with the
aim to deﬁne risk areas and help to target pre-travel advice.
2. Methods
2.1. Travel-related cases
We selected infections that are frequently associated with interna-
tional travel and typically transmitted either via sexual transmission
route (referred here as sexually transmitted infections – STIs; gonor-
rhoea and syphilis) or faecal-oral route (referred here as food- and
water-borne infections – FWIs; hepatitis A, shigellosis, Salmonella gas-
troenteritis, typhoid fever, paratyphoid fever, and campylobacteriosis).
Data were extracted from the NIDR during the deﬁned time period
(from 1 January 1995 to 31 December 2015). All these infections are
notiﬁable in Finland according to the Communicable Disease Act and
Decree, and the NIDR is maintained by the National Institute for Health
and Welfare (THL). Campylobacter and non-typhoid Salmonellae infec-
tions are laboratory-notiﬁable only, while the other infections are also
notiﬁed by the physician. The notiﬁcation system is based on the un-
ique personal identiﬁcation number. Laboratory notiﬁcation includes
basic demographics and limited travel information; whereas the phy-
sician's notiﬁcation contains further information about country of in-
fection, date of onset of symptoms, and other relevant epidemiological
data.
Total number of cases, number and percentage of travel-related
cases, average annual number, median age with range, sex distribution
and percentage of Finnish-born travel-related cases were deﬁned for
each infection. For syphilis, only Finnish-born travel-related cases were
included in further analyses, since chronic infections could not be dis-
tinguished from acute infections. Salmonella infections were divided in
three groups (a) Salmonella enterica subsp. enterica serovar Typhi (S.
Typhi), or (b) Salmonella enterica subsp. enterica serovar Paratyphi (S.
Paratyphi A, B, C), or (c) all the other Salmonella subspecies and ser-
ovars (non-typhoid Salmonellae).
2.2. Travel data
Travel statistics, collected by Statistics Finland, were extracted from
the pre-existing online Statistics Finland database. The initial data was
based on telephone interviews and extrapolated to the Finnish popu-
lation with the appropriate weights [15]. Travel statistics included the
number of travellers by selected countries and geographical regions
from 2000 and onwards (destination-speciﬁc data only for countries
receiving more than 10,000 Finnish travellers per year during
2000–2011, and more than 50,000 per year during 2012–2015).
Travel data from 2012 and onwards were not fully comparable with
those of earlier years due to the revised data collection method that
came into force in 2012 (the upper age limit was extended from 74 to
84 years). Therefore, the overall time series broke and data had to be
analysed separately.
2.3. Risk calculations
Travel statistics were used as denominator when estimating the
risks. Crude attack rates (ARs) per 100,000 travellers with 95% con-
ﬁdence intervals (CIs) were calculated by dividing the number of no-
tiﬁed travel-associated cases by the estimated total number of travellers
to a speciﬁc country or region. ARs were only calculated for countries
with complete travel data for entire time period. We calculated overall
risks during 2012–2015 and trends in risks during 2000–2011. We used
binomial regression with log-link for 2000–2011, when yearly statistics
were comparable.
Data analysis was performed by Microsoft Oﬃce Excel and STATA
14 (StataCorp, College Station, TX).
3. Results
3.1. Descriptive analysis
During the 21-year period, 2304 STIs and 70,929 FWIs were notiﬁed
as travel-related (26% and 53% of the total, respectively) (Table 1). For
the various infections, the total numbers of travel-related cases ranged
between 414 (hepatitis A) and 40,198 (salmonellosis together). The
lowest proportion (16%) of travel-related cases was scored for syphilis
and the highest (92%) for typhoid fever. The proportions of travel-re-
lated cases were stable during the whole period for gonorrhoea, sy-
philis, shigellosis and salmonellosis together. The proportion increased
from 2000 to 2004 to 2010–2015 for hepatitis A and campylobacter-
iosis. The predominance of males was most prominent in STIs. The
median age was lowest among typhoid fever and paratyphoid fever
cases (26 and 28 years of age, respectively) and highest among tra-
vellers who contracted syphilis (44 years of age). Overall, 91% of the
cases were born in Finland; in typhoid fever the predominance of Fin-
nish-born cases was less prominent (56%) (Table 1).
The highest case numbers were notiﬁed among travellers returning
from Egypt (shigellosis), India (typhoid fever), Turkey (paratyphoid
fever), Thailand (Salmonella gastroenteritis, gonorrhoea, and campylo-
bacteriosis) and Russia (syphilis, hepatitis A). During the 21-year
period, 56% of all FWIs cases we studied were notiﬁed with Salmonella
gastroenteritis, followed by campylobacteriosis (40%). The 22% and
Table 1
Main characteristics of notiﬁable travel-related infections. International travellers. Finland, 1995–2015.
Infection Total number of
cases
Number of TRC (% of
total)
Average annual number
of TRC
Median age of TRC
(range)
Sex distribution of TRC (%
male)
Finnish-born among
TRC (%)
STIs 8824 2304 (26)
gonorrhoea 5162 1723 (33) 82 35 (15–76) 88 84
syphilisa 3662 581 (16) 28 44 (19–78) 96 100
FWIs 134,361 70,929 (53)
hepatitis A 1699 414 (24) 20 34 (0–80) 55 78
shigellosis 2244 1948 (87) 93 37 (0–79) 39 90
typhoid fever 98 90 (92) 4 26 (0–73) 52 56
paratyphoid fever 143 125 (87) 6 28 (1–73) 46 90
Salmonella gastroenteritisb 53,115 39,983 (75) 1904 38 (1–87) 55 95
campylobacteriosis 77,062 28,369 (37) 1351 37 (0–91) 51 86
TRC = travel-related cases.
STIs = sexually transmitted infections.
FWIs = food- and waterborne infections.
a For syphilis only Finnish-born travel-related cases were included since chronic infections cannot be distinguished from acute infections.
b Caused by non-typhoid Salmonellae, i.e. other Salmonella subspecies and serovars than S. enterica subsp. enterica ser. Typhi/Paratyphi.
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17% of them respectively, were returnees from Thailand. India ac-
counted for 50% of typhoid fever and 26% of paratyphoid fever cases.
During the 21-year period, 17% of the travel-related hepatitis A cases in
the NIDR were notiﬁed with travel history to Russia.
For shigellosis, data on serogroup was available for 97% of the
travel-related cases (Table 2). The serogroup distribution of isolates was
stable over time. Regarding Salmonella gastroenteritis cases, data on
subspecies and/or serovar was available for 98% of the travel-related
cases. For S. Enteritidis, Spain was the most frequent country of in-
fection, whereas for S. Typhimurium and S. group B (O:4), Thailand.
Among these serovars, the case number declined with time for S. En-
teritidis and S. Typhimurium and increased for S. group B (O:4).
3.2. Trend analysis for 2000–2011
Our analysis showed an increasing (but not signiﬁcant) trend in risk
of campylobacteriosis in all regions, except Africa where the risk
peaked in 2005 (data not shown). In other FWIs the trend was mainly
declining during the period (Fig. 1).
We found a signiﬁcant declining trend for STIs among travellers to
Russia and the Baltic countries. The risks for STIs remained stable in
Asia and Oceania, increased non-signiﬁcantly in Western Europe, or
ﬂuctuated without a clear trend in other European regions (data not
shown).
3.3. Overall risks for 2012–2015
During 2012–2015, the overall attack rate was highest for campy-
lobacteriosis (26 per 100,000 travellers) followed by Salmonella gas-
troenteritis (17 per 100,000 travellers), and lowest for typhoid fever
and paratyphoid fever (0.050 per 100,000 travellers, each) (Fig. 2).
Among the regions deﬁned by Statistics Finland, Asia and Oceania
accounted for the highest overall risk for the STIs, salmonellosis, and
campylobacteriosis, while Africa for hepatitis A, and shigellosis
(Table 3). At country-level, the highest risk mainly occurred among
travellers returning from Thailand. For hepatitis A, Hungary accounted
for the highest overall risk during 2012–2015 (Table 4).
Regarding Finnish travellers' risks of being notiﬁed with syphilis or
gonorrhoea after returning from European countries (including Russia),
decreased from 0.78 per 100,000 in 2012 to 0.76 in 2015. The only
European country with increasing risks during 2012–2015 was Spain,
where risk of gonorrhoea increased from 0.45 to 1.9 per 100,000 tra-
vellers, and risk of syphilis changed from 0.30 to 1.2 per 100,000 tra-
vellers. The highest overall risk of gonorrhoea among Finnish returnees
from Europe during 2012–2015 occurred for Poland, although it was
declining from 1.7 to 0.77 per 100,000 travellers, and no syphilis cases
were notiﬁed with Polish travel history during the period.
4. Discussion
During the last two decades, substantial amount of studies were
published on travellers morbidity, and possible risk factors of con-
tracting diseases abroad. However, lacking the data on population at
risk and time at risk, networks such as GeoSentinel are unable to pro-
vide destination-speciﬁc risks or incidence rates, and can calculate only
the proportionate morbidity. In our study, we were able to use a travel
denominator, therefore destination-speciﬁc risks have been provided.
With the exception of campylobacteriosis, we found a decreasing
trend for all the studied notiﬁable infections. In the country-speciﬁc
analysis, Thailand accounted for the highest overall ARs among coun-
tries, except hepatitis A, where travel to Hungary was associated with
the highest risk. Among the regions, Asia and Oceania, and Africa were
found to show the highest risks. The NIDR and travel data are not
available for most countries and, accordingly, investigations combining
such nation-wide data for computing risks for diﬀerent notiﬁable in-
fections are scarce.
Table 2
Distribution of travel-related cases of Salmonella gastroenteritisa and shigellosis by sub-
species/serovar (S. gastroenteritis) or serogroup (shigellosis). International travellers.
Finland, 1995–2015.
Number of travel-related cases Proportion (%)
Salmonella gastroenteritisa 39,983 100
S. Enteritidis 16,559 41
S. Typhimurium 2510 6
S. group B (O:4) 1720 4
other 18,482 46
not available 712 2
Shigellosis 1984 100
Shigella sonnei 1313 66
Shigella ﬂexneri 428 22
Shigella boydii 94 5
Shigella disenteriae 60 3
not available 53 3
a Caused by non-typhoid Salmonellae, i.e. other Salmonella subspecies and serovars
than S. enterica subsp. enterica ser. Typhi/Paratyphi.
Fig. 1. Signiﬁcant trends in region-speciﬁc attack rates in notiﬁable
food- and waterborne infections. International travellers. Finland,
2000–2011.
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4.1. FWIs ﬁndings
Gastro-intestinal infections constitute the vast majority (approxi-
mately 80%) of all reported notiﬁable travel-related diseases as it was
showed among Norwegian holiday travellers and Swedish international
travellers [10,16]. In a study on cases of campylobacteriosis, salmo-
nellosis, giardiasis and shigellosis notiﬁed between 2009 and 2010 to
the Norwegian NIDR, 91% of all cases with gastrointestinal infections
had information on place of infection, and of those 65% were notiﬁed
as acquired abroad [8]. In our analysis, the overall proportion of travel-
related campylobacteriosis, Salmonella gastroenteritis, and shigellosis
cases was over the half of the total cases notiﬁed with the studied in-
fections. In Norway and Sweden, campylobacteriosis was found to be
the most frequent travel-related infection, followed by salmonellosis,
giardiasis and shigellosis [8,16].
Regarding the risk of Salmonella gastroenteritis, we found an in-
creasing trend among travellers returning from Thailand during
2000–2008, which coincided with a previous Finnish study [14].
Fig. 2. Overall crude attack rates of infections per 100,000 persons. International travellers. Finland, 2012–2015.
Salmonella gastroenteritis: infections caused by non-typhoid Salmonellae, i.e. other Salmonella subspecies and serovars than S. enterica subsp. enterica ser. Typhi/Paratyphi.
Due to the lack of travel data (denominator) for Africa in 2015, cases with travel history to Africa in that year were excluded from the overall crude attack rates calculations.
Table 3
Overall crude attack rates and the 95% conﬁdence intervals (CI) by regions. International travellers. Finland, 2012–2015.
Infection Statistics Finland regions
Africaa America Asia and
Oceania
Nordic countriesb Russia and the Baltic
countries
Southern Europe and East
Mediterranean countries
Western and Eastern
Europe
Sexually transmitted infections
gonorrhoea 6.7 (4.2–11) 1.5 (0.94–2.5) 11 (9.5–13) 0.24 (0.14–0.41) 0.40 (0.28–0.56) 0.77 (0.58–1.0) 0.77 (0.59–1.0)
syphilis 0 0.58
(0.26–1.28)
1.4 (0.93–2.1) 0.037
(0.0092–0.15)
0.14 (0.082–0.25) 0.24 (0.15–0.39) 0.16 (0.090–0.29)
Food- and waterborne infections
hepatitis A 4.5 (2.5–7.9) 0 0.96
(0.58–1.6)
0.018
(0.0026–0.13)
0.084 (0.040–0.18) 0.14 (0.070–0.26) 0.044 (0.014–0.14)
shigellosis 35 (28–43) 2.9 (2.0–4.1) 9.6 (8.2–11) 0 0.060 (0.025–0.14) 0.44 (0.30–0.63) 0.22 (0.13–0.37)
salmonellosis 178 (163–195) 17 (14–19) 157 (151–164) 0.48 (0.33–0.71) 4.3 (3.8–4.7) 21 (20–22) 4.0 (3.5–4.5)
campylobacteriosis 99 (88–112) 15 (13–18) 135 (129–141) 2.3 (2.0–2.8) 4.9 (4.5–5.4) 49 (47–50) 22 (21–23)
a For Africa ARs were calculated only for the period 2012–2014, since travel denominator was not available in 2015.
b Except Finland.
Table 4
Overall crude attack rates and the 95% conﬁdence intervals (CI) in the most common travel destinations. International travellers. Finland, 2012–2015.
Infections Top three countries with highest overall risks (95% CI)
First Second Third
Sexually transmitted infections
gonorrhoea Thailand, 21.3 (17.8–25.6) Turkey, 1.4 (0.79–2.5) Poland, 1.2 (0.52–3.0)
syphilis Thailand, 3.1 (1.9–5.0) Russia, 0.84 (0.44–1.6) Spain, 0.43 (0.24–0.77)
Food- and waterborne infections
hepatitis A Hungary, 0.38 (0.10–1.5) Czech Republic, 0.35 (0.05–2.5) and
Turkey, 0.35 (0.11–1.1)
Russia, 0.29 (0.11–0.77)
shigellosis Thailand, 2.6 (1.5–4.3) Turkey, 1.9 (1.1–3.0) USA, 0.73 (0.31–1.8)
salmonellosis Thailand, 302.8 (288.5–317.7) Turkey, 90.4 (84.3–97.0) Latvia, 26.4 (21.2–32.8)
campylobacteriosis Thailand, 225.6 (213.3–238.5) Hungary, 120.1 (108.9–132.4) Turkey, 119.0 (111.9–126.5)
Countries with continuous unique travel data during 2012–2015: Austria, Belgium, Czech Republic, Denmark, Estonia, France, Germany, Greece, Hungary, Italy, Latvia, Netherlands,
Norway, Poland, Portugal, Russia, Spain, Sweden, Switzerland, Thailand, Turkey, United Kingdom, USA.
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However, we also detected a decreasing trend during 2009–2011,
which continued during 2012–2015. Similarly, among returnees from
Thailand with campylobacteriosis, the risk constantly increased during
2000–2011, then declined during 2012–2015.
For shigellosis, both the number of cases during the 21-year period,
and the risk during 2000–2011 were highest among returnees from
Egypt. Additionally, we found an increasing risk among travellers re-
turning from Thailand during 2013–2015. Our results on shigellosis
serogroups showed the same picture as the few previous studies re-
porting travel-related shigellosis [17,18]; both the relative importance
and the distribution of serogroups were in line with those ﬁgures.
In our analysis, Africa accounted for the highest overall risk for
hepatitis A during 2012–2015. Among Swedish international travellers,
Africa, and especially East Africa was associated with the highest he-
patitis A incidence rate [6,16]. The attack rate of hepatitis A among
Dutch travellers was calculated for the period 2003–2011 and found to
be the highest for returnees from Morocco followed by India and Brazil
[7]. The lack of country-level travel data for Africa during 2012–2015
did not allow us to calculate country-speciﬁc risks, however, a con-
siderable amount (one out of three) of travel-related cases were notiﬁed
with travel history to an African country. During the 21-year period, the
highest number of the travel-related hepatitis A cases was notiﬁed with
travel history to Russia, where we found a constantly declining trend in
risk during 2000–2011. At country level, the risk of hepatitis A during
2012–2015 was highest among travellers returning from Hungary, the
Czech Republic, and Turkey yet our AR calculations for that 4-year-long
period were based on low case numbers. Vaccination status of the cases
were not available, however; vaccination against hepatitis A for Finnish
travellers to these countries is recommended in the in the national
travel guidelines.
Due to the low case numbers, trends could not be evaluated at
country-level for typhoid fever and paratyphoid fever. In addition, the
denominator was not equally available for the most important coun-
tries, either because only low number of travellers (< 50.000 per year
during 2012–2015) were received, or travel information was not
complete for the entire period. Incomplete travel information also af-
fected shigellosis, where we lacked the denominator and could there-
fore not calculate the risks for Egypt during 2012–2015. However, one
out of three Shigella infections was contracted in Egypt during the
period, suggesting a substantial risk for Egypt.
4.2. STIs ﬁndings
The overall STIs trend was declining or stable for all the regions
during 2000–2011. During 2012–2015, the risk of contracting syphilis
or gonorrhoea remained declining among travellers returning from
Thailand, the country with highest risk. A recently published systematic
review on trend studies in syphilis described an increasing trend of
syphilis among men who have sex with men in the United States and
Western Europe after 2000 [19]. Another literature review found a
substantially higher incidence of syphilis in Eastern Europe than that
observed in the EU-15 countries (member states of the European Union
as of 31 December 2003) [20]. ECDC's annual epidemiological reports
showed that during 2010–2015, the overall syphilis rates increased
across Europe, particularly among men, and the overall rate of reported
gonorrhoea infections more than doubled across Europe between 2008
and 2014. These data are somewhat contradictory to our ﬁndings;
however they are not fully comparable. The highest risk of gonorrhoea
among Finnish returnees from Europe during 2012–2015 was recorded
for Poland, where it, however decreased from 2012 to 2015. The only
European country recorded with increasing risk of acquisition of go-
norrhoea or syphilis during 2012–2015 was Spain.
A Norwegian register-based study focused on STI cases with travel
history to Thailand found that 5% of gonorrhoea cases and 3% of sy-
philis cases were connected to Thailand during 1993–1998 [21]. In
Sweden, 34% of all the gonorrhoea cases had acquired the infection
abroad during 2001–2008 [22]. During 2007–2011, 50% of the
Swedish cases in the 35 years or older age groups were travel-related
[23] and during 2009–2013, Thailand was found as the country with
the highest incidence of sexually transmitted diseases [16]. Consistent
with these studies, also in our data Thailand ranked the ﬁrst in attack
rates.
Although acute and chronic syphilis could not be diﬀerentiated from
the NIDR data, we decided to include syphilis in our analysis, as the
importance of travel-related infections has been documented in Finland
[24]. We assumed, that country of infection is more inaccurate in for-
eign-born cases therefore we excluded all the foreign-born travel-re-
lated cases from the analysis. The majority of them were born in the
same country in which their infections were reported to be acquired.
4.3. Why do trends in risks change?
The experienced decrease in FWIs might be related to better hy-
gienic measures introduced in the destination, having proper pre-travel
advice, or increased awareness of travellers. Salmonella gastroenteritis
trend has declined possibly because of successful control campaigns in
agriculture [25], especially poultry. The increase of group B can be
explained by increase of multiresistant monophasic S. Typhimurium
since 2012 (mostly from Thailand), and has also been detected in other
countries [26]. Finnish pre-travel advice on treatment of travellers'
diarrhoea has changed during the past decade: antibiotics are no longer
recommended for mild or moderate diarrhoea and they are advised
only if the patient has high fever or gross blood in stools or if the
symptoms are exceptionally vigorous or the patient is in poor condition
[27]. These changes were implemented because travellers' diarrhoea is
mostly a spontaneously resolving disease and new data showed that its
antibiotic treatment increases substantially the risk of contracting
multi-drug resistant bacteria while travelling [28–30].
In our data, the majority of STI cases were males. We assume that
they adopted, at a signiﬁcant extent, risky sexual behaviours during
their trip. The experienced decline in risk in STIs might be due to po-
sitive changes in epidemiology at the relevant destinations, and/or in-
creasing awareness in appropriate preventive strategies (e.g. using
condom). Since increase of incidences of syphilis and gonorrhoea have
been observed in many countries, while in Finland remained stable in
the last 5 years, it is also possible, that among travellers practicing more
risky behaviours become less common, especially at destinations known
to be attached with higher potential risk (e.g. Thailand, Russia).
Previously, appropriate preventive measures, like vaccination (he-
patitis A), improved hygienic standards at travel destination (faecal-
orally transmitted infections) and pre-travel health consultation
(sexually transmitted infections) have been found to be eﬀective
[31,32].
By calculating risks, we considered the changes in travel, although
we did not have the possibility to indicate tourism changes neither to
evaluate preventive strategies.
4.4. Limitations
Besides the speciﬁc limitations mentioned above, a number of
general limitations also deserve to be discussed. The information on
country of infection was missing in a range of 1% (paratyphoid fever)
and 53% (campylobacteriosis) of the reviewed notiﬁcations (syphilis
39%, hepatitis A 21%, gonorrhoea 20%, and shigellosis, typhoid fever,
and non-typhoid Salmonellae infections each less than 10%).
Consequently, a substantial number of cases could not be included in
the country-speciﬁc analyses. Regarding the proportion of missing
country data, all the studied infections are mandatory for physicians to
notify in Finland, with the exception of campylobacteriosis, and non-
typhoid Salmonellae infections, which are only laboratory notiﬁable.
Diﬀerences in the ﬂow of information can possibly explain the numbers
of missing travel information between campylobacteriosis (53%) and
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non-typhoid Salmonellae infections (< 10%): the reference laboratory
at THL had requested this information retrospectively for non-typhoid
Salmonellae infections if it had not been initially provided, while such
approach had not been applied for campylobacteriosis, since the iso-
lates are not routinely sent to THL.
It is noteworthy that this study does not describe the risk of infec-
tions in general but, instead, the risk of notiﬁable diseases for which
travel information was available and thus leaves out the major causa-
tive agents of many diseases. An example of this is travellers' diarrhoea:
it is most commonly caused by diarrheagenic E. coli [11,33] such as
ETEC and EAEC, which far outnumber Campylobacter and Salmonella as
causative agents, yet are not notiﬁable.
Furthermore, our data did not cover travellers who had sought
medical care only abroad. In a recent study on Finnish travellers to
(sub)tropical regions, 79% had health problems, 69% had travellers'
diarrhoea and 10% consulted a doctor during travel [3]. Likewise, in a
study using the database of SOS International, an assistance organiza-
tion covering 95% of Finns requiring aid abroad, acute gastroenteritis
was the most common diagnosis during 2010–2012 [12].
We were not able to identify immigrants or their children, who are
often visiting friends and relatives in their country of origin, neither
foreign tourists to Finland, since information on country of birth and
nationality in the NIDR was limited. However, given the size of those
groups versus the volume of returning travellers, we believe that our
results would not be considerably diﬀerent if we had been able to ex-
clude those groups.
Travel details such as age distribution of travellers and exact
duration of trips were not available and did thus not allow calculation
of person-time at risk. Changes in travel statistics methodology limited
our analysis and only allowed to perform the trend analysis during
2000–2011. Country-speciﬁc data could be given only for countries
which had high enough traveller counts to be recorded in the Statistics
Finland database separately. Finally, lack of conﬁdence intervals of the
denominator did not allow us to take its uncertainty into account when
calculating crude attack rates.
5. Conclusions
Combining nation-wide databases of infectious diseases register and
travel statistics provided destination-speciﬁc risks of contracting noti-
ﬁable infections abroad and trends in risks. Despite the fact, that we
observed positive trends in risks of contracting infections abroad, we
recommend to maintain, or regarding high risk destinations, even
strengthen public awareness. Travellers should be reminded that visits
to Europe and Thailand are not without risk either, and pre-travel
counselling is warranted also to these destinations. For Europe, vacci-
nations and advice are needed especially to areas with risk of hepatitis
A. For Thailand, counselling should, in addition to including informa-
tion on vaccinations and prevention and treatment of travellers' diar-
rhoea (elevated risks of salmonellosis, campylobacteriosis, shigellosis),
increase the awareness of the risk of STIs (not only HIV but also go-
norrhoea and others) and encourage the use of condoms. Our data can
be helpful for health care professionals providing travel advice.
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